Posado-Dominguez, L.; Feito-Perez, J.; Escribano-Iglesias, M.; Bragado Pascual, M.; Fonseca Sánchez, E.
Steroid-Refractory Cholestatic Immune-Mediated Hepatitis Following Nivolumab Therapy in an Elderly Patient with Metastatic Melanoma: A Rare and Challenging Presentation. Curr. Oncol. 2025, 32, 663.
https://doi.org/10.3390/curroncol32120663
AMA Style
Posado-Dominguez L, Feito-Perez J, Escribano-Iglesias M, Bragado Pascual M, Fonseca Sánchez E.
Steroid-Refractory Cholestatic Immune-Mediated Hepatitis Following Nivolumab Therapy in an Elderly Patient with Metastatic Melanoma: A Rare and Challenging Presentation. Current Oncology. 2025; 32(12):663.
https://doi.org/10.3390/curroncol32120663
Chicago/Turabian Style
Posado-Dominguez, Luis, Jorge Feito-Perez, MarÃa Escribano-Iglesias, Miriam Bragado Pascual, and Emilio Fonseca Sánchez.
2025. "Steroid-Refractory Cholestatic Immune-Mediated Hepatitis Following Nivolumab Therapy in an Elderly Patient with Metastatic Melanoma: A Rare and Challenging Presentation" Current Oncology 32, no. 12: 663.
https://doi.org/10.3390/curroncol32120663
APA Style
Posado-Dominguez, L., Feito-Perez, J., Escribano-Iglesias, M., Bragado Pascual, M., & Fonseca Sánchez, E.
(2025). Steroid-Refractory Cholestatic Immune-Mediated Hepatitis Following Nivolumab Therapy in an Elderly Patient with Metastatic Melanoma: A Rare and Challenging Presentation. Current Oncology, 32(12), 663.
https://doi.org/10.3390/curroncol32120663
